Probiotic Supplements Market in Canada 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	147 Pages	TechNavio	December, 2023	INF18413881

Best Price Guarantee
Price	from $2,500
Length	147 Pages
Publisher	TechNavio
Published Date	December, 2023
SKU	INF18413881

Probiotic Supplements Market In Canada 2024-2028

The probiotic supplements market in Canada is forecasted to grow by USD 75.75 mn during 2023-2028, accelerating at a CAGR of 6.33% during the forecast period. The report on the probiotic supplements market in Canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased awareness about lifestyle-related diseases, rising awareness and benefits of probiotic supplements, and increasing prevalence of digestive problems.

Technavio's probiotic supplements market in Canada is segmented as below:

By Disease Type

Gastrointestinal diseases
Infectious diseases
Others

By Type

Bacteria
Yeast

By End-user

Human probiotics
Animal probiotics

This study identifies the intensive research and development in probiotic supplements as one of the prime reasons driving the probiotic supplements market in Canada growth during the next few years. Also, rise in demand for weight management products and availability of probiotic supplements in online stores will lead to sizable demand in the market.

The report on the probiotic supplements market in Canada covers the following areas:

Probiotic supplements market in Canada sizing
Probiotic supplements market in Canada forecast
Probiotic supplements market in Canada industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading probiotic supplements market in Canada vendors that include American Biologics LLC, Archer Daniels Midland Co., Biena Inc., BioGaia AB, Biotix Care, Church and Dwight Co. Inc., CUSTOM PROBIOTICS Inc., Genuine Health Inc., International Flavors and Fragrances Inc., Jamieson Wellness Inc., Koninklijke DSM NV, Lallemand Inc., Mars Inc., Natural Factors Nutritional Products Ltd., NOVA Essentials Inc., PetLab Co., Reckitt Benckiser Group Plc, The Clorox Co., The Procter and Gamble Co., and Kerry Group Plc. Also, the probiotic supplements market in Canada analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 08: Parent market; Exhibit 09: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 10: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 11: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%); Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Probiotic supplements market in Canada 2018 - 2022; Exhibit 16: Historic Market Size - Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million); 4.2 Disease Type Segment Analysis 2018 - 2022; Exhibit 17: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million); 4.3 Type Segment Analysis 2018 - 2022; Exhibit 18: Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 End-user Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 20: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Disease Type: 6.1 Market segments; Exhibit 27: Chart on Disease Type - Market share 2023-2028 (%); Exhibit 28: Data Table on Disease Type - Market share 2023-2028 (%); 6.2 Comparison by Disease Type; Exhibit 29: Chart on Comparison by Disease Type; Exhibit 30: Data Table on Comparison by Disease Type; 6.3 Gastrointestinal diseases - Market size and forecast 2023-2028; Exhibit 31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million); Exhibit 32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million); Exhibit 33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%); Exhibit 34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%); 6.4 Infectious diseases - Market size and forecast 2023-2028; Exhibit 35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million); Exhibit 36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million); Exhibit 37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%); Exhibit 38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Exhibit 39: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibit 40: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibit 41: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibit 42: Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Disease Type; Exhibit 43: Market opportunity by Disease Type ($ million); Exhibit 44: Data Table on Market opportunity by Disease Type ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 45: Chart on Type - Market share 2023-2028 (%); Exhibit 46: Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Exhibit 47: Chart on Comparison by Type; Exhibit 48: Data Table on Comparison by Type; 7.3 Bacteria - Market size and forecast 2023-2028; Exhibit 49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million); Exhibit 50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million); Exhibit 51: Chart on Bacteria - Year-over-year growth 2023-2028 (%); Exhibit 52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%); 7.4 Yeast - Market size and forecast 2023-2028; Exhibit 53: Chart on Yeast - Market size and forecast 2023-2028 ($ million); Exhibit 54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million); Exhibit 55: Chart on Yeast - Year-over-year growth 2023-2028 (%); Exhibit 56: Data Table on Yeast - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Exhibit 57: Market opportunity by Type ($ million); Exhibit 58: Data Table on Market opportunity by Type ($ million)
8 Market Segmentation by End-user: 8.1 Market segments; Exhibit 59: Chart on End-user - Market share 2023-2028 (%); Exhibit 60: Data Table on End-user - Market share 2023-2028 (%); 8.2 Comparison by End-user; Exhibit 61: Chart on Comparison by End-user; Exhibit 62: Data Table on Comparison by End-user; 8.3 Human probiotics - Market size and forecast 2023-2028; Exhibit 63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million); Exhibit 64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million); Exhibit 65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%); Exhibit 66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%); 8.4 Animal probiotics - Market size and forecast 2023-2028; Exhibit 67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million); Exhibit 68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million); Exhibit 69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%); 8.5 Market opportunity by End-user; Exhibit 71: Market opportunity by End-user ($ million); Exhibit 72: Data Table on Market opportunity by End-user ($ million)
9 Customer Landscape: 9.1 Customer landscape overview; Exhibit 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 74: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends; 11.1 Overview; 11.2 Vendor landscape; Exhibit 75: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 76: Overview on factors of disruption; 11.4 Industry risks; Exhibit 77: Impact of key risks on business; 12.1 Vendors covered; Exhibit 78: Vendors covered; 12.2 Market positioning of vendors; Exhibit 79: Matrix on vendor position and classification; 12.3 American Biologics LLC; Exhibit 80: American Biologics LLC - Overview; Exhibit 81: American Biologics LLC - Product / Service; Exhibit 82: American Biologics LLC - Key offerings; 12.4 Archer Daniels Midland Co.; Exhibit 83: Archer Daniels Midland Co. - Overview; Exhibit 84: Archer Daniels Midland Co. - Business segments; Exhibit 85: Archer Daniels Midland Co. - Key offerings; Exhibit 86: Archer Daniels Midland Co. - Segment focus; 12.5 Biena Inc.; Exhibit 87: Biena Inc. - Overview; Exhibit 88: Biena Inc. - Product / Service; Exhibit 89: Biena Inc. - Key offerings; 12.6 BioGaia AB; Exhibit 90: BioGaia AB - Overview; Exhibit 91: BioGaia AB - Business segments; Exhibit 92: BioGaia AB - Key news; Exhibit 93: BioGaia AB - Key offerings; Exhibit 94: BioGaia AB - Segment focus; 12.7 Biotix Care; Exhibit 95: Biotix Care - Overview; Exhibit 96: Biotix Care - Product / Service; Exhibit 97: Biotix Care - Key offerings; 12.8 Church and Dwight Co. Inc.; Exhibit 98: Church and Dwight Co. Inc. - Overview; Exhibit 99: Church and Dwight Co. Inc. - Business segments; Exhibit 100: Church and Dwight Co. Inc. - Key offerings; Exhibit 101: Church and Dwight Co. Inc. - Segment focus; 12.9 Genuine Health Inc.; Exhibit 102: Genuine Health Inc. - Overview; Exhibit 103: Genuine Health Inc. - Product / Service; Exhibit 104: Genuine Health Inc. - Key offerings; 12.10 International Flavors and Fragrances Inc.; Exhibit 105: International Flavors and Fragrances Inc. - Overview; Exhibit 106: International Flavors and Fragrances Inc. - Business segments; Exhibit 107: International Flavors and Fragrances Inc. - Key news; Exhibit 108: International Flavors and Fragrances Inc. - Key offerings; Exhibit 109: International Flavors and Fragrances Inc. - Segment focus; 12.11 Jamieson Wellness Inc.; Exhibit 110: Jamieson Wellness Inc. - Overview; Exhibit 111: Jamieson Wellness Inc. - Business segments; Exhibit 112: Jamieson Wellness Inc. - Key news; Exhibit 113: Jamieson Wellness Inc. - Key offerings; Exhibit 114: Jamieson Wellness Inc. - Segment focus; 12.12 Kerry Group Plc; Exhibit 115: Kerry Group Plc - Overview; Exhibit 116: Kerry Group Plc - Business segments; Exhibit 117: Kerry Group Plc - Key news; Exhibit 118: Kerry Group Plc - Key offerings; Exhibit 119: Kerry Group Plc - Segment focus; 12.13 Koninklijke DSM NV; Exhibit 120: Koninklijke DSM NV - Overview; Exhibit 121: Koninklijke DSM NV - Business segments; Exhibit 122: Koninklijke DSM NV - Key news; Exhibit 123: Koninklijke DSM NV - Key offerings; Exhibit 124: Koninklijke DSM NV - Segment focus; 12.14 Lallemand Inc.; Exhibit 125: Lallemand Inc. - Overview; Exhibit 126: Lallemand Inc. - Product / Service; Exhibit 127: Lallemand Inc. - Key offerings; 12.15 Natural Factors Nutritional Products Ltd.; Exhibit 128: Natural Factors Nutritional Products Ltd. - Overview; Exhibit 129: Natural Factors Nutritional Products Ltd. - Product / Service; Exhibit 130: Natural Factors Nutritional Products Ltd. - Key offerings; 12.16 NOVA Essentials Inc.; Exhibit 131: NOVA Essentials Inc. - Overview; Exhibit 132: NOVA Essentials Inc. - Product / Service; Exhibit 133: NOVA Essentials Inc. - Key offerings; 12.17 Reckitt Benckiser Group Plc; Exhibit 134: Reckitt Benckiser Group Plc - Overview; Exhibit 135: Reckitt Benckiser Group Plc - Business segments; Exhibit 136: Reckitt Benckiser Group Plc - Key offerings; Exhibit 137: Reckitt Benckiser Group Plc - Segment focus; 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 138: Inclusions checklist; Exhibit 139: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 140: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 141: Research methodology; Exhibit 142: Validation techniques employed for market sizing; Exhibit 143: Information sources; 13.5 List of abbreviations; Exhibit 144: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Vendor Market Positioning; Exhibits8: Parent market; Exhibits9: Market Characteristics; Exhibits10: Offerings of vendors included in the market definition; Exhibits11: Market segments; Exhibits12: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits13: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits14: Chart on Canada: Year-over-year growth 2023-2028 (%); Exhibits15: Data Table on Canada: Year-over-year growth 2023-2028 (%); Exhibits16: Historic Market Size - Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million); Exhibits17: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million); Exhibits18: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits20: Five forces analysis - Comparison between 2023 and 2028; Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits26: Chart on Market condition - Five forces 2023 and 2028; Exhibits27: Chart on Disease Type - Market share 2023-2028 (%); Exhibits28: Data Table on Disease Type - Market share 2023-2028 (%); Exhibits29: Chart on Comparison by Disease Type; Exhibits30: Data Table on Comparison by Disease Type; Exhibits31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million); Exhibits32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million); Exhibits33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%); Exhibits34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%); Exhibits35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million); Exhibits36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million); Exhibits37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%); Exhibits39: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits40: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits41: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits42: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits43: Market opportunity by Disease Type ($ million); Exhibits44: Data Table on Market opportunity by Disease Type ($ million); Exhibits45: Chart on Type - Market share 2023-2028 (%); Exhibits46: Data Table on Type - Market share 2023-2028 (%); Exhibits47: Chart on Comparison by Type; Exhibits48: Data Table on Comparison by Type; Exhibits49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Bacteria - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Yeast - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Yeast - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Yeast - Year-over-year growth 2023-2028 (%); Exhibits57: Market opportunity by Type ($ million); Exhibits58: Data Table on Market opportunity by Type ($ million); Exhibits59: Chart on End-user - Market share 2023-2028 (%); Exhibits60: Data Table on End-user - Market share 2023-2028 (%); Exhibits61: Chart on Comparison by End-user; Exhibits62: Data Table on Comparison by End-user; Exhibits63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million); Exhibits64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million); Exhibits65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%); Exhibits67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million); Exhibits68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million); Exhibits69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%); Exhibits71: Market opportunity by End-user ($ million); Exhibits72: Data Table on Market opportunity by End-user ($ million); Exhibits73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits74: Impact of drivers and challenges in 2023 and 2028; Exhibits75: Overview on Criticality of inputs and Factors of differentiation; Exhibits76: Overview on factors of disruption; Exhibits77: Impact of key risks on business; Exhibits78: Vendors covered; Exhibits79: Matrix on vendor position and classification; Exhibits80: American Biologics LLC - Overview; Exhibits81: American Biologics LLC - Product / Service; Exhibits82: American Biologics LLC - Key offerings; Exhibits83: Archer Daniels Midland Co. - Overview; Exhibits84: Archer Daniels Midland Co. - Business segments; Exhibits85: Archer Daniels Midland Co. - Key offerings; Exhibits86: Archer Daniels Midland Co. - Segment focus; Exhibits87: Biena Inc. - Overview; Exhibits88: Biena Inc. - Product / Service; Exhibits89: Biena Inc. - Key offerings; Exhibits90: BioGaia AB - Overview; Exhibits91: BioGaia AB - Business segments; Exhibits92: BioGaia AB - Key news; Exhibits93: BioGaia AB - Key offerings; Exhibits94: BioGaia AB - Segment focus; Exhibits95: Biotix Care - Overview; Exhibits96: Biotix Care - Product / Service; Exhibits97: Biotix Care - Key offerings; Exhibits98: Church and Dwight Co. Inc. - Overview; Exhibits99: Church and Dwight Co. Inc. - Business segments; Exhibits100: Church and Dwight Co. Inc. - Key offerings; Exhibits101: Church and Dwight Co. Inc. - Segment focus; Exhibits102: Genuine Health Inc. - Overview; Exhibits103: Genuine Health Inc. - Product / Service; Exhibits104: Genuine Health Inc. - Key offerings; Exhibits105: International Flavors and Fragrances Inc. - Overview; Exhibits106: International Flavors and Fragrances Inc. - Business segments; Exhibits107: International Flavors and Fragrances Inc. - Key news; Exhibits108: International Flavors and Fragrances Inc. - Key offerings; Exhibits109: International Flavors and Fragrances Inc. - Segment focus; Exhibits110: Jamieson Wellness Inc. - Overview; Exhibits111: Jamieson Wellness Inc. - Business segments; Exhibits112: Jamieson Wellness Inc. - Key news; Exhibits113: Jamieson Wellness Inc. - Key offerings; Exhibits114: Jamieson Wellness Inc. - Segment focus; Exhibits115: Kerry Group Plc - Overview; Exhibits116: Kerry Group Plc - Business segments; Exhibits117: Kerry Group Plc - Key news; Exhibits118: Kerry Group Plc - Key offerings; Exhibits119: Kerry Group Plc - Segment focus; Exhibits120: Koninklijke DSM NV - Overview; Exhibits121: Koninklijke DSM NV - Business segments; Exhibits122: Koninklijke DSM NV - Key news; Exhibits123: Koninklijke DSM NV - Key offerings; Exhibits124: Koninklijke DSM NV - Segment focus; Exhibits125: Lallemand Inc. - Overview; Exhibits126: Lallemand Inc. - Product / Service; Exhibits127: Lallemand Inc. - Key offerings; Exhibits128: Natural Factors Nutritional Products Ltd. - Overview; Exhibits129: Natural Factors Nutritional Products Ltd. - Product / Service; Exhibits130: Natural Factors Nutritional Products Ltd. - Key offerings; Exhibits131: NOVA Essentials Inc. - Overview; Exhibits132: NOVA Essentials Inc. - Product / Service; Exhibits133: NOVA Essentials Inc. - Key offerings; Exhibits134: Reckitt Benckiser Group Plc - Overview; Exhibits135: Reckitt Benckiser Group Plc - Business segments; Exhibits136: Reckitt Benckiser Group Plc - Key offerings; Exhibits137: Reckitt Benckiser Group Plc - Segment focus; Exhibits138: Inclusions checklist; Exhibits139: Exclusions checklist; Exhibits140: Currency conversion rates for US$; Exhibits141: Research methodology; Exhibits142: Validation techniques employed for market sizing; Exhibits143: Information sources; Exhibits144: List of abbreviations